Page last updated on July 16, 2024
Bellevue Life Sciences Acquisition Corp. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-04-17 16:31:22 EDT.
Filings
10-K filed on 2024-04-17
Bellevue Life Sciences Acquisition Corp. filed a 10-K at 2024-04-17 16:31:22 EDT
Accession Number: 0001193125-24-099137
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
Item 1C. Cybersecurity As a blank check company, we do not have any operations and our sole business activity has been to search for and consummate a business combination. However, because we have investments in our Trust Account and bank deposits and we depend on the digital technologies of third parties, we and third parties may be subject to attacks on or security breaches in our or their systems. Because of our reliance on the technologies of third parties, we also depend upon the personnel and the processes of third parties to protect against cybersecurity threats, and we have no personnel or processes of our own for this purpose. In the event of a cybersecurity incident impacting us, the management team will report to the Board and provide updates on the management team’s incident response plan for addressing and mitigating any risks associated with such an incident. As an early-stage company without significant investments in data security protection, we may not be sufficiently protected against such occurrences. We also lack sufficient resources to adequately protect against, or to investigate and remediate any vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have material adverse consequences on our business and lead to financial loss.
Company Information
Name | Bellevue Life Sciences Acquisition Corp. |
CIK | 0001840425 |
SIC Description | Surgical & Medical Instruments & Apparatus |
Ticker | BLAC - NasdaqBLACR - NasdaqBLACU - NasdaqBLACW - Nasdaq |
Website | |
Category | Emerging growth company |
Fiscal Year End | December 30 |